BF Biosciences Limited (PSX:BFBIO)
Pakistan
· Delayed Price · Currency is PKR 141.54
-4.82 (-3.29%)
At close: Apr 28, 2026
BF Biosciences Revenue
BF Biosciences had revenue of 2.14B PKR in the quarter ending March 31, 2026, with 42.32% growth. This brings the company's revenue in the last twelve months to 8.86B, up 78.71% year-over-year. In the fiscal year ending June 30, 2025, BF Biosciences had annual revenue of 5.84B with 59.55% growth.
Revenue (ttm)
8.86B
Revenue Growth
+78.71%
P/S Ratio
1.52
Revenue / Employee
15.37M
Employees
535
Market Cap
12.50B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| MCB investment management | 4.97B |
| Khairpur Sugar Mills | 10.86B |
| Siemens (Pakistan) Engineering | 9.15B |
| Apna Microfinance Bank | 414.37M |
| The Thal Industries Corporation | 42.27B |
| Hum Network | 11.04B |
| Macter International | 11.58B |
| Avanceon | 14.42B |